WHO. Options for the use of human H5N1 influenza vaccines and the WHO H5N1 vaccine stockpile. WHO
WHO/HSE/EPR/GIP/2008.1
- English - PDF [pdf 159kb]
![]()
Contents
Executive summary
1. Characteristics of candidate human H5N1 influenza vaccines
2. Options for using human H5N1 influenza vaccines
3. Options for using the WHO H5N1 vaccine stockpile
See Also:
Latest articles in those days:
- T cell help is a limiting factor for rare anti-influenza memory B cells to reenter germinal centers and generate potent broadly neutralizing antibodies 2 days ago
- Wild birds drive the introduction, maintenance, and spread of H5N1 clade 2.3.4.4b high pathogenicity avian influenza viruses in Spain, 2021-2022 2 days ago
- [preprint]FluNexus: a versatile web platform for antigenic prediction and visualization of influenza A viruses 2 days ago
- Salpingitis and multiorgan lesions caused by highly pathogenic avian influenza A(H5N1) virus in a cat associated with consumption of recalled raw milk in California 2 days ago
- Detection of highly pathogenic avian influenza A(H5N1) virus 2.3.4.4b in alpacas 2 days ago
[Go Top] [Close Window]


